0.6833

6.56% 0.0421

Pre-market: .71 0.0267 +3.92%

Io Biotech Inc (IOBT)

Overview News Price History Financials Discussions Forecast

Io Biotech Inc stock is traded at $0.6833, with a volume of 986.33K. It is up +6.56% in the last 24 hours and down -18.53% over the past month. IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Previous Close:

$0.6412

Open:

$0.6689

24h Volume:

986.33K

Relative Volume:

0.27

Market Cap:

$49.16M

Revenue:

Net Income/Loss:

$-86.08M

P/E Ratio:

-0.3167

EPS:

-2.1574

Net Cash Flow:

$-72.06M

1W Performance:

-6.91%

1M Performance:

-18.53%

6M Performance:

-52.88%

1Y Performance:

-17.68%

1-Day Range:

$0.66

$0.7239

1-Week Range:

$0.588

$0.776

52-Week Range:

$0.3234

$2.79

Io Biotech Inc Stock (IOBT) Company Profile

Name

Io Biotech Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

(457) 070-2980

Address

OLE MAALOES VEH 3, COPENHAGEN

Employee

Twitter

Next Earnings Date

2025-08-08

Latest SEC Filings

IOBT's Discussions on Twitter

Compare IOBT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IOBT Io Biotech Inc	0.6833	46.13M	0	-86.08M	-72.06M	-2.1574
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Io Biotech Inc Stock (IOBT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-30-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Sep-30-25	Downgrade	TD Cowen	Buy → Hold

Io Biotech Inc Stock (IOBT) Latest News

Dec 02, 2025

IO Biotech (IOBT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

Dec 01, 2025

How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews

Dec 01, 2025

Nov 27, 2025

Will IO Biotech Inc. stock reach all time highs in 2025July 2025 Levels & Growth Focused Stock Reports - BỘ NỘI VỤ

Nov 27, 2025

Research Recommendations For IO Biotech Inc (IOBT): Here is What You Should Know - fostersleader.com

Nov 27, 2025

Analyst Downgrade: How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Movers & Free Growth Oriented Trading Recommendations - moha.gov.vn

Nov 27, 2025

Nov 26, 2025

How strong is IO Biotech Inc. stock balance sheetMarket Performance Recap & Long-Term Safe Investment Plans - BỘ NỘI VỤ

Nov 26, 2025

Aug Wrap: What margin trends mean for IO Biotech Inc. stockJuly 2025 Decliners & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ

Nov 26, 2025

IO Biotech Announces Participation in Upcoming December Investor Conferences - The Manila Times

Nov 26, 2025

IO Biotech (Nasdaq: IOBT) to Join Evercore, Piper Sandler December Investor Events - Stock Titan

Nov 26, 2025

Nov 24, 2025

IOBTRemeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - mx.advfn.com

Nov 24, 2025

It makes sense and dollars to buy IO Biotech Inc (IOBT) stock - Setenews

Nov 24, 2025

Nov 23, 2025

IO Biotech (NASDAQ:IOBT) Stock Rating Upgraded by Wall Street Zen - Defense World

Nov 23, 2025

Ligand Pharmaceuticals (NASDAQ:LGND) and IO Biotech (NASDAQ:IOBT) Financial Review - Defense World

Nov 23, 2025

Nov 22, 2025

IO Biotech announces resignation of chief accounting officer and new appointment - Investing.com Australia

Nov 22, 2025

Nov 21, 2025

IO Biotech Announces Resignation of Chief Accounting Officer - MSN

Nov 21, 2025

IO Biotech announces resignation of chief accounting officer and new appointment By Investing.com - Investing.com South Africa

Nov 21, 2025

IO Biotech Announces Management Changes - TradingView

Nov 21, 2025

[8-K] IO Biotech, Inc. Reports Material Event | IOBT SEC FilingForm 8-K - Stock Titan

Nov 21, 2025

IO Biotech, Inc. Announces Executive Changes - MarketScreener

Nov 21, 2025

Can IO Biotech Inc. stock withstand economic slowdown2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - The Spec

Nov 20, 2025

Nov 19, 2025

Piper Sandler reiterates Overweight rating on IO Biotech stock By Investing.com - Investing.com South Africa

Nov 19, 2025

Is IO Biotech Inc. stock entering bullish territoryJuly 2025 Review & Fast Gaining Stock Reports - newser.com

Nov 19, 2025

Is IO Biotech Inc. stock a top momentum playWeekly Stock Analysis & Daily Price Action Insights - newser.com

Nov 19, 2025